Echo IQ Limited (EIQ.XA)

0.1050 0.0000 (0.00%) As of 11:37AM AEST. Market open.

Echo IQ Limited

309 George St
Level 4, Suite 404
Sydney, NSW 2000
Australia
61 2 9159 3719
https://www.echoiq.ai

Sector(s): 
Industry: 
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Andrew Grover	Executive Chairman	265.2k	N/A	N/A
Mr. Kimber Rothwell	Chief Executive Officer	N/A	N/A	N/A
Jacki McAvenna	Chief Financial Officer	N/A	N/A	N/A
Mr. Philip Woolff	Chief Operating Officer	N/A	N/A	N/A
Sean Bryceland	Chief Technology Officer	N/A	N/A	N/A
Prof. David Playford	Chief Medical Officer- Medical Advisory Team	N/A	N/A	N/A
Mr. Donald L. Fowler	President of Echo IQ USA	N/A	N/A	N/A
Ms. Jessamyn Sarah Lyons AGIA, B.Com.	Company Secretary	N/A	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Echo IQ Limited provides artificial intelligence diagnostics tool that enhance the diagnosis of structural heart disease in Australia and the United Kingdom. The company also EchoSolvTM, a software for identification Aortic Stenosis heart condition. It primarily serves physicians and health systems. The company was formerly known as Houston We Have Limited and changed its name to EchoIQ Limited in December 2021. Echo IQ Limited is based in Sydney, Australia.

Corporate Governance

Echo IQ Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.